Northera

Active Ingredient(s): Droxidopa
FDA Approved: * February 18, 2014
Pharm Company: * CHELSEA THERAPEUTICS INC
Category: Neurological Disorders

Droxidopa (INN; trade name Northera; also known as L-DOPS, L-threo-dihydroxyphenylserine, L-threo-DOPS and SM-5688) is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitter norepinephrine (noradrenaline).[1] Unlike norepinephrine, droxidopa is capable of crossing the protective blood–brain barrier (BBB).[1] Contents 1 Medical uses 2 Side effects 3 Pharmacology 4 Chemistry 5 History 5.1 Clinical trials 6 Research 7 Reference... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Northera 100 mg Oral Capsule

NDC: 67386-820

Labeler:

Lundbeck LLC

Northera 200 mg Oral Capsule

NDC: 67386-821

Labeler:

Lundbeck LLC

Northera 300 mg Oral Capsule

NDC: 67386-822

Labeler:

Lundbeck LLC

Northera 100 mg/1 Oral Capsule

NDC: 76320-100

Labeler:

Chelsea Therapeutics Inc

Northera 200 mg/1 Oral Capsule

NDC: 76320-200

Labeler:

Chelsea Therapeutics Inc

Northera 300 mg/1 Oral Capsule

NDC: 76320-300

Labeler:

Chelsea Therapeutics Inc